7AY-71253-08594
2 vaccinations
4 coded responses
23 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 371 / TN
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Moderna
-
2021-03-05
Survey response — day 0, dose 1MedDRA: Erythema, Rash macular, Self-medication — Feeling: Good · Headache, Rash, not including the immediate area around the injection siteFree text: My skin began to turn red and splotchy. This happen 5 hours after receiving the vaccine. I have multiple sclerosis and expected to have some type reaction. I immediately took a Benadryl and the redness faded after about an hour.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction, Depression, Diabetes mellitus, Hypertension, Multiple sclerosis, Pre-existing disease — Feeling: Good · Headache, Fatigue or tiredness, DiarrheaFree text: I take several medications for high blood pressure, diabetes, depression, and multiple sclerosis (Ocrevus) So far, my reactions have been mild and manageable.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-19
- 2021-03-26
-
2021-04-01
Dose 2 — Moderna
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Diabetes mellitus, Hypertension, Multiple sclerosis, Pre-existing disease — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: I have multiple sclerosis, diabetes, and high blood pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-07-01
- 2021-09-30
-
2022-04-03
Survey response — 12 months, dose 2MedDRA: Dyspnoea, Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: Shortness of breath and fatigueMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Moderna | |
| 2 | 2021-04-01 | Moderna |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): My skin began to turn red and splotchy. This happen 5 hours after receiving the vaccine. I have multiple sclerosis and expected to have some type reaction. I immediately took a Benadryl and the redness faded after about an hour.
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): I take several medications for high blood pressure, diabetes, depression, and multiple sclerosis (Ocrevus) So far, my reactions have been mild and manageable.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): I have multiple sclerosis, diabetes, and high blood pressure
Release 11 — 12 months, dose 2
Symptoms: Shortness of breath and fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Depression | ✓ | ✓ | ○ |
| SRO | Diabetes mellitus | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Hypertension | ✓ | ✓ | ✓ |
| SRO | Multiple sclerosis | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash macular | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release